AAAAAA

   
Results: 1-23 |
Results: 23
NEW ERA OF TREATMENT IN BREAST-CANCER - NEOADJUVANT THERAPY WITHOUT SURGERY
Authors: BRETZ PD DREISBACH PB KAMINSKY DB BACUS SS
Citation: Pd. Bretz et al., NEW ERA OF TREATMENT IN BREAST-CANCER - NEOADJUVANT THERAPY WITHOUT SURGERY, European journal of cancer, 34, 1998, pp. 488-488
BETACELLULIN-PSEUDOMONAS TOXIN FUSION PROTEINS BIND BUT ARE NOT CYTOTOXIC TO CELLS EXPRESSING HER4 - CORRELATION OF EGFR FOR CYTOTOXIC ACTIVITY
Authors: MIXAN B COHEN BD BACUS SS FELL HP SIEGALL CB
Citation: B. Mixan et al., BETACELLULIN-PSEUDOMONAS TOXIN FUSION PROTEINS BIND BUT ARE NOT CYTOTOXIC TO CELLS EXPRESSING HER4 - CORRELATION OF EGFR FOR CYTOTOXIC ACTIVITY, Oncogene, 16(9), 1998, pp. 1209-1215
THE ONCOGENIC ERBB-2 ERBB-3 HETERODIMER IS A SURROGATE RECEPTOR OF THE EPIDERMAL GROWTH-FACTOR AND BETACELLULIN/
Authors: PINKASKRAMARSKI R LENFERINK AEG BACUS SS LYASS L VANDEPOLL MLM KLAPPER LN TZAHAR E SELA M VANZOELEN EJJ YARDEN Y
Citation: R. Pinkaskramarski et al., THE ONCOGENIC ERBB-2 ERBB-3 HETERODIMER IS A SURROGATE RECEPTOR OF THE EPIDERMAL GROWTH-FACTOR AND BETACELLULIN/, Oncogene, 16(10), 1998, pp. 1249-1258
ERBB TYROSINE KINASES AND THE 2 NEUREGULIN FAMILIES CONSTITUTE A LIGAND-RECEPTOR NETWORK (VOL 18, PG 6090, 1998)
Authors: PINKASKRAMARSKI R SHELLY M GUARINO BC WANG LM LYASS L ALROY I ALIMANDI M KUO A MOYER JD LAVI S EISENSTEIN M RATZKIN BJ SEGER R BACUS SS PIERCE JH ANDREWS GC YARDEN Y
Citation: R. Pinkaskramarski et al., ERBB TYROSINE KINASES AND THE 2 NEUREGULIN FAMILIES CONSTITUTE A LIGAND-RECEPTOR NETWORK (VOL 18, PG 6090, 1998), Molecular and cellular biology (Print), 18(12), 1998, pp. 7602-7602
ERBB TYROSINE KINASES AND THE 2 NEUREGULIN FAMILIES CONSTITUTE A LIGAND-RECEPTOR NETWORK
Authors: PINKASKRAMARSKI R SHELLY M GUARINO BC WANG LM LYASS L ALROY I ALAMANDI M KUO A MOYER JD LAVI S EISENSTEIN M RATZKIN BJ SEGAR R BACUS SS PIERCE JH ANDREWS GC YARDEN Y
Citation: R. Pinkaskramarski et al., ERBB TYROSINE KINASES AND THE 2 NEUREGULIN FAMILIES CONSTITUTE A LIGAND-RECEPTOR NETWORK, Molecular and cellular biology, 18(10), 1998, pp. 6090-6101
EPIREGULIN IS A POTENT PAN-ERBB LIGAND THAT PREFERENTIALLY ACTIVATES HETERODIMERIC RECEPTOR COMPLEXES
Authors: SHELLY M PINKASKRAMARSKI R GUARINO BC WATERMAN H WANG LM LYASS L ALIMANDI M KUO A BACUS SS PIERCE JH ANDREWS GC YARDEN Y
Citation: M. Shelly et al., EPIREGULIN IS A POTENT PAN-ERBB LIGAND THAT PREFERENTIALLY ACTIVATES HETERODIMERIC RECEPTOR COMPLEXES, The Journal of biological chemistry, 273(17), 1998, pp. 10496-10505
THE UNIFORM APPROACH TO BREAST FINE-NEEDLE ASPIRATION BIOPSY
Authors: ABATI A ABELE J BACUS SS BEDROSSIAN C BEERLINE D BIBBO M CADY B COVELL J DAVEY D DAWSON A FORNAGE B FOSTER R FRABLE W GOLDFISCHER M GROHS H HENRY M HIJAZI Y HINDLE W HOWELL L KAMINSKY D KATZ R KLINE T KOSS L LANNIN DR LAYFIELD L LEIMAN G LEWIS M LINDHOLM K LJUNG BM MASOOD S MIYAZAKI J NEWSTEAD G OSHAUGHNESSY J PAGE D POWERS C ROLLINS S ROSENTHAL D SANCHEZ MA SCHMIDT W SIDAWY M SILVERMAN J SNEIGE N STAHL RE STANLEY M THOMAS P VAZQUEZ M WAISMAN J WOLMAN S WORSHAM GF WUNDERLICH C YAWN B
Citation: A. Abati et al., THE UNIFORM APPROACH TO BREAST FINE-NEEDLE ASPIRATION BIOPSY, Diagnostic cytopathology, 16(4), 1997, pp. 295-311
TRANSGENIC MICE WITH P53-RESPONSIVE LACZ - P53 ACTIVITY VARIES DRAMATICALLY DURING NORMAL DEVELOPMENT AND DETERMINES RADIATION AND DRUG-SENSITIVITY IN-VIVO
Authors: KOMAROVA EA CHERNOV MV FRANKS R WANG KH ARMIN G ZELNICK CR CHIN DM BACUS SS STARK GR GUDKOV AV
Citation: Ea. Komarova et al., TRANSGENIC MICE WITH P53-RESPONSIVE LACZ - P53 ACTIVITY VARIES DRAMATICALLY DURING NORMAL DEVELOPMENT AND DETERMINES RADIATION AND DRUG-SENSITIVITY IN-VIVO, EMBO journal, 16(6), 1997, pp. 1391-1400
NEU DIFFERENTIATION FACTOR (HEREGULIN) ACTIVATES A P53-DEPENDENT PATHWAY IN CANCER-CELLS
Authors: BACUS SS YARDEN Y GUDKOV A KEYOMARSI K
Citation: Ss. Bacus et al., NEU DIFFERENTIATION FACTOR (HEREGULIN) ACTIVATES A P53-DEPENDENT PATHWAY IN CANCER-CELLS, Laboratory investigation, 76(1), 1997, pp. 71-71
INTRACELLULAR-LOCALIZATION OF P53 TUMOR-SUPPRESSOR PROTEIN IN GAMMA-IRRADIATED CELLS IS CELL-CYCLE-REGULATED AND DETERMINED BY THE NUCLEUS
Authors: KOMAROVA EA ZELNICK CR CHIN D ZEREMSKI M GLEIBERMAN AS BACUS SS GUDKOV AV
Citation: Ea. Komarova et al., INTRACELLULAR-LOCALIZATION OF P53 TUMOR-SUPPRESSOR PROTEIN IN GAMMA-IRRADIATED CELLS IS CELL-CYCLE-REGULATED AND DETERMINED BY THE NUCLEUS, Cancer research, 57(23), 1997, pp. 5217-5220
NEU DIFFERENTIATION FACTOR (HEREGULIN) ACTIVATES A P53-DEPENDENT PATHWAY IN CANCER-CELLS
Authors: BACUS SS YARDEN Y OREN M CHIN DM LYASS L ZELNICK CR KAZAROV A TOYOFUKU W GRAYBABLIN J BEERLI RR HYNES NE NIKIFOROV M HAFFNER R GUDKOV A KEYOMARSI K
Citation: Ss. Bacus et al., NEU DIFFERENTIATION FACTOR (HEREGULIN) ACTIVATES A P53-DEPENDENT PATHWAY IN CANCER-CELLS, Oncogene, 12(12), 1996, pp. 2535-2547
NEW DIFFERENTIATION FACTOR (HEREGULIN) ACTIVATES A P53-DEPENDENT PATHWAY IN CANCER-CELLS
Authors: BACUS SS KEYOMARSI K
Citation: Ss. Bacus et K. Keyomarsi, NEW DIFFERENTIATION FACTOR (HEREGULIN) ACTIVATES A P53-DEPENDENT PATHWAY IN CANCER-CELLS, The FASEB journal, 10(6), 1996, pp. 1561-1561
AN IMMUNOLOGICAL APPROACH REVEALS BIOLOGICAL DIFFERENCES BETWEEN THE 2 NDF HEREGULIN RECEPTORS, ERBB-3 AND ERBB4/
Authors: CHEN XM LEVKOWITZ G TZAHAR E KARUNAGARAN D LAVI S BENBARUCH N LEITNER O RATZKIN BJ BACUS SS YARDEN Y
Citation: Xm. Chen et al., AN IMMUNOLOGICAL APPROACH REVEALS BIOLOGICAL DIFFERENCES BETWEEN THE 2 NDF HEREGULIN RECEPTORS, ERBB-3 AND ERBB4/, The Journal of biological chemistry, 271(13), 1996, pp. 7620-7629
TYPE-1 RECEPTOR TYROSINE KINASES ARE DIFFERENTIALLY PHOSPHORYLATED INMAMMARY-CARCINOMA AND DIFFERENTIALLY ASSOCIATED WITH STEROID-RECEPTORS
Authors: BACUS SS CHIN D YARDEN Y ZELNICK CR STERN DF
Citation: Ss. Bacus et al., TYPE-1 RECEPTOR TYROSINE KINASES ARE DIFFERENTIALLY PHOSPHORYLATED INMAMMARY-CARCINOMA AND DIFFERENTIALLY ASSOCIATED WITH STEROID-RECEPTORS, The American journal of pathology, 148(2), 1996, pp. 549-558
THE UNIFORM APPROACH TO BREAST FINE-NEEDLE ASPIRATION BIOPSY - A SYNOPSIS
Authors: ABATI A ABELE J BACUS SS BEDROSSIAN C BEERLINE D BIBBO M CADY B COVELL J DAVEY D DAWSON A FORNAGE B FOSTER R FRABLE W GOLDFISCHER M GROHS H HENRY M HIJAZI Y HINDLE W HOWELL L KAMINSKY D KATZ R KLINE T KOSS LG LANNIN DR LAYFIELD L LEIMAN G LEWIS M LINDHOLM K LJUNG BM MASOOD S MIYAZAKI J NEWSTEAD G OSHAUGHNESSY J PAGE D POWERS C ROLLINS S ROSENTHAL D SANCHEZ MA SCHMIDT W SIDAWY M SILVERMAN J SNEIGE N STAHL RE STANLEY M THOMAS P VAZQUEZ M WAISMAN J WOLMAN S WUNDERLICH C YAWN B
Citation: A. Abati et al., THE UNIFORM APPROACH TO BREAST FINE-NEEDLE ASPIRATION BIOPSY - A SYNOPSIS, Acta cytologica, 40(6), 1996, pp. 1120-1126
HER4 EXPRESSION CORRELATES WITH CYTOTOXICITY DIRECTED BY A HEREGULIN-TOXIN FUSION PROTEIN
Authors: SIEGALL CB BACUS SS COHEN BD PLOWMAN GD MIXAN B CHACE D CHIN DM GOETZE A GREEN JM HELLSTROM I HELLSTROM KE FELL HP
Citation: Cb. Siegall et al., HER4 EXPRESSION CORRELATES WITH CYTOTOXICITY DIRECTED BY A HEREGULIN-TOXIN FUSION PROTEIN, The Journal of biological chemistry, 270(13), 1995, pp. 7625-7630
SUPPRESSED TRANSFORMATION AND INDUCED-DIFFERENTIATION OF HER-2 NEU-OVEREXPRESSING BREAST-CANCER CELLS BY EMODIN
Authors: ZHANG LS CHANG CJ BACUS SS HUNG MC
Citation: Ls. Zhang et al., SUPPRESSED TRANSFORMATION AND INDUCED-DIFFERENTIATION OF HER-2 NEU-OVEREXPRESSING BREAST-CANCER CELLS BY EMODIN, Cancer research, 55(17), 1995, pp. 3890-3896
NEU DIFFERENTIATION FACTOR (NDF HEREGULIN) INDUCES EXPRESSION OF INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1) - IMPLICATIONS TO MAMMARY-TUMORS
Authors: BACUS SS GUDKOV AV ZELNICK CR STERN RK CHIN DM LUPU R YARDEN Y
Citation: Ss. Bacus et al., NEU DIFFERENTIATION FACTOR (NDF HEREGULIN) INDUCES EXPRESSION OF INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1) - IMPLICATIONS TO MAMMARY-TUMORS, Journal of cellular biochemistry, 1994, pp. 228-228
DNA-PLOIDY IN BREAST CARCINOMAS - CORRELATION WITH HER-2 NEU AMPLIFICATION AND OVEREXPRESSION/
Authors: LUKAS JJ BACUS SS SLAMON DJ PRESS MF
Citation: Jj. Lukas et al., DNA-PLOIDY IN BREAST CARCINOMAS - CORRELATION WITH HER-2 NEU AMPLIFICATION AND OVEREXPRESSION/, Clinical research, 42(1), 1994, pp. 10000056-10000056
ERBB-2 ANTISENSE OLIGONUCLEOTIDES INHIBIT THE PROLIFERATION OF BREAST-CARCINOMA CELLS WITH ERBB-2 ONCOGENE AMPLIFICATION
Authors: COLOMER R LUPU R BACUS SS GELMANN EP
Citation: R. Colomer et al., ERBB-2 ANTISENSE OLIGONUCLEOTIDES INHIBIT THE PROLIFERATION OF BREAST-CARCINOMA CELLS WITH ERBB-2 ONCOGENE AMPLIFICATION, British Journal of Cancer, 70(5), 1994, pp. 819-825
MEDULLARY CARCINOMA IS ASSOCIATED WITH EXPRESSION OF INTERCELLULAR-ADHESION MOLECULE-1 - IMPLICATION TO ITS MORPHOLOGY AND ITS CLINICAL BEHAVIOR
Authors: BACUS SS ZELNICK CR CHIN DM YARDEN Y KAMINSKY DB BENNINGTON J WEN DZ MARCUS JN PAGE DL
Citation: Ss. Bacus et al., MEDULLARY CARCINOMA IS ASSOCIATED WITH EXPRESSION OF INTERCELLULAR-ADHESION MOLECULE-1 - IMPLICATION TO ITS MORPHOLOGY AND ITS CLINICAL BEHAVIOR, The American journal of pathology, 145(6), 1994, pp. 1337-1348
EXPRESSION OF THE ERBB-2 FAMILY OF GROWTH-FACTOR RECEPTORS AND THEIR LIGANDS IN BREAST CANCERS - IMPLICATION FOR TUMOR BIOLOGY AND CLINICALBEHAVIOR
Authors: BACUS SS ZELNICK CR PLOWMAN G YARDEN Y
Citation: Ss. Bacus et al., EXPRESSION OF THE ERBB-2 FAMILY OF GROWTH-FACTOR RECEPTORS AND THEIR LIGANDS IN BREAST CANCERS - IMPLICATION FOR TUMOR BIOLOGY AND CLINICALBEHAVIOR, American journal of clinical pathology, 102(4), 1994, pp. 190000013-190000024
NEU DIFFERENTIATION FACTOR (HEREGULIN) INDUCES EXPRESSION OF INTERCELLULAR-ADHESION MOLECULE-1 - IMPLICATIONS FOR MAMMARY-TUMORS
Authors: BACUS SS GUDKOV AV ZELNICK CR CHIN D STERN R STANCOVSKI I PELES E BENBARUCH N FARBSTEIN H LUPU R WEN DZ SELA M YARDEN Y
Citation: Ss. Bacus et al., NEU DIFFERENTIATION FACTOR (HEREGULIN) INDUCES EXPRESSION OF INTERCELLULAR-ADHESION MOLECULE-1 - IMPLICATIONS FOR MAMMARY-TUMORS, Cancer research, 53(21), 1993, pp. 5251-5261
Risultati: 1-23 |